Clinical Trial Update: IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing indobufen to aspirin for antiplatelet therapy after coronary drug-eluting stent implantation in elderly patients with acute cor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• Aspirin (Aspirin)
• Indobufen (indobufen)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Coronary Artery Disease, Antiplatelet Drugs | Phase 4 | Status: RECRUITING